Extremely high plasma
triglyceride (TG) concentration is a recognized risk factor for
acute pancreatitis (AP). In order to evaluate the therapeutic efficacy of
plasma-exchange plasmapheresis in treating patients with severe
hypertriglyceridemia (sHTG), 17 patients who had not responded to conventional medical
therapy (
fat-free diet plus
pharmaceutical interventions) were referred for therapeutic
plasma exchange (TPE) in a multicenter frame case series study. Two hundred seventeen TPE sessions were performed, and
therapy is ongoing for five (30%) of the patients.
After treatment, the mean plasma TG and total
cholesterol concentrations were significantly reduced from 1929 and 510 mg/dL, to 762 and 227 mg/dL, respectively (P < or = 0.001 in both cases). In most cases, the interval between treatments was related to the clinical presentation and individual circumstances. The removal of TG-rich
lipoproteins prevented relapses of AP. In this case series, TPE is confirmed as a safe and reliable method for treating patients with refractory sHTG when a severe complication, such as AP, is clinically demonstrated or can be actively prevented. Therefore, in cases where standard medical approaches fail to promote the clearance of TGs from plasma and a high risk of first or second hypertriglyceridemic
pancreatitis persists, TPE provides a therapeutic option for preventing life-threatening sHTG.